Brinzolamide
Who holds supplier records for Brinzolamide? 10 organisations hold a current record for Brinzolamide: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5), Italy (2), Spain (1), Greece (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Brinzolamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/brinzolamide
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Brinzolamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Neuland Laboratories LimitedIndiaActive DMF 25817, 26936, 39920 +1 · latest filing Jun 2024
- Biocon LimitedIndiaActive DMF 28933 · latest filing Sept 2015
- DUKE CHEM SASpain Company GMP cert on recordActive DMF 32202 · latest filing Feb 2018
- FDC LimitedIndia Company GMP cert on recordActive DMF 39512 · latest filing Mar 2024
- ICROM SRLItaly Company GMP cert on recordActive DMF 25478 · latest filing Nov 2011
- INDOCO REMEDIES LTDIndia Company GMP cert on recordActive DMF 28134 · latest filing Apr 2014
- INDUSTRIALE CHIMICA SRLItaly Company GMP cert on recordActive DMF 25918 · latest filing Mar 2012
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 40566 · latest filing Sept 2024
- Pharmathen S.A.Greece Company GMP cert on recordActive DMF 34167 · latest filing Oct 2019
- SCI PHARMTECH INCTaiwanActive DMF 29746 · latest filing Sept 2015
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Brinzolamide are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Bachem SA, Succursale de VionnazSwitzerland · Inactive DMF 25324 · filed Sept 2011
- ALP PHARM BEIJING CO LTDInactive DMF 23789 · filed Apr 2010
- Viwit Pharmaceutical Co., Ltd.China · Inactive DMF 22851 · filed Jun 2009
Overview
Brinzolamide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL220491).
Chemical identity
- IUPAC name
- (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
- Canonical SMILES
- CCN[C@H]1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC
- InChIKey
- HCRKCZRJWPKOAR-JTQLQIEISA-N
- Synonyms
- AL-4862, Azopt, Brinzolamida, Brinzolamide, Brinzolamide component of azarga, Brinzolamide component of simbrinza, NSC-760050, AL 4862, CHEBI:3176, AZARGA COMPONENT BRINZOLAMIDE, SIMBRINZA COMPONENT BRINZOLAMIDE, brinzolamidum
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Carbonic Anhydrase Inhibitor
- Mechanism of action
- Carbonic Anhydrase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Brinzolamide?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Brinzolamide: Neuland Laboratories Limited (India), Biocon Limited (India), DUKE CHEM SA (Spain), FDC Limited (India), ICROM SRL (Italy), INDOCO REMEDIES LTD (India), INDUSTRIALE CHIMICA SRL (Italy) and MICRO LABS LTD (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Brinzolamide Drug Master Files are active?
Neuland Laboratories Limited (DMF 25817, 26936), Biocon Limited (DMF 28933), DUKE CHEM SA (DMF 32202), FDC Limited (DMF 39512), ICROM SRL (DMF 25478), INDOCO REMEDIES LTD (DMF 28134), INDUSTRIALE CHIMICA SRL (DMF 25918) and MICRO LABS LTD (DMF 40566) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Brinzolamide records mean?
3 organisations have only inactive Type II DMFs for Brinzolamide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Brinzolamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Brinzolamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.